$26.13M Market Cap.
ONMD Market Cap. (MRY)
ONMD Shares Outstanding (MRY)
ONMD Assets (MRY)
Total Assets
$463.06K
Total Liabilities
$13.32M
Total Investments
$0
ONMD Income (MRY)
Revenue
$1.02M
Net Income
-$23.21M
Operating Expense
$8.25M
ONMD Cash Flow (MRY)
CF Operations
$8.22M
CF Investing
-$43.76K
CF Financing
-$8.43M
ONMD Dividends (MRY)
Period | Dividends | Yield % | Growth % | Payout Ratio | Coverage Ratio |
|---|---|---|---|---|---|
2023 | $0 | 0% | 0% | 0% | - |
2022 | $0 | 0% | 0% | 0% | - |
2021 | $0 | 0% | - | 0% | - |
ONMD Balance Sheet (MRY)
Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
Total Assets | $463,057 (-66.30%) | $1,374,028 (55.60%) | $883,060 |
Assets Current | $364,186 (-71.79%) | $1,290,931 (54.92%) | $833,293 |
Assets Non-Current | $98,871 (18.98%) | $83,097 (66.97%) | $49,767 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | -$12,859,606 (-20.53%) | -$10,669,323 (-87.10%) | -$5,702,612 |
Property Plant & Equipment Net | $98,871 (18.98%) | $83,097 (66.97%) | $49,767 |
Cash & Equivalents | $47,008 (-82.64%) | $270,859 (-61.27%) | $699,320 |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 |
Deferred Revenue | $253,997 (38.28%) | $183,683 (-71.40%) | $642,350 |
Total Investments | $0 (0%) | $0 (0%) | $0 |
Investments Current | $0 (0%) | $0 (0%) | $0 |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 |
Inventory | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $151,640 (699.16%) | $18,975 (-79.32%) | $91,742 |
Trade & Non-Trade Payables | $4,184,398 (268.75%) | $1,134,752 (49.54%) | $758,815 |
Accumulated Retained Earnings (Deficit) | -$55,082,677 (-72.80%) | -$31,877,221 (-25.94%) | -$25,310,924 |
Tax Assets | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $233,370 (0%) | $0 (0%) | $0 |
Total Debt | $5,101,316 (-49.16%) | $10,034,144 (104.91%) | $4,896,897 |
Debt Current | $4,636,293 (-45.39%) | $8,490,000 (153.43%) | $3,350,000 |
Debt Non-Current | $465,023 (-69.88%) | $1,544,144 (-0.18%) | $1,546,897 |
Total Liabilities | $13,322,663 (10.62%) | $12,043,351 (82.87%) | $6,585,672 |
Liabilities Current | $12,833,058 (30.84%) | $9,808,435 (106.44%) | $4,751,165 |
Liabilities Non-Current | $489,605 (-78.09%) | $2,234,916 (21.83%) | $1,834,507 |
ONMD Income Statement (MRY)
Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
Revenues | $1,021,651 (14.93%) | $888,970 (-18.58%) | $1,091,777 |
Cost of Revenue | $1,149,551 (3.91%) | $1,106,285 (-8.21%) | $1,205,184 |
Selling General & Administrative Expense | $6,388,480 (143.53%) | $2,623,230 (45.58%) | $1,801,947 |
Research & Development Expense | $1,631,613 (129.69%) | $710,362 (10.52%) | $642,765 |
Operating Expenses | $8,246,350 (133.14%) | $3,537,121 (36.19%) | $2,597,173 |
Interest Expense | $749,213 (174.76%) | $272,682 (239.56%) | -$195,381 |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$23,205,456 (-471.98%) | -$4,057,060 (-37.95%) | -$2,940,869 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 |
Net Income | -$23,205,456 (-471.98%) | -$4,057,060 (-37.95%) | -$2,940,869 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 |
Net Income Common Stock | -$23,205,456 (-471.98%) | -$4,057,060 (-37.95%) | -$2,940,869 |
Weighted Average Shares | $23,572,232 (94.30%) | $12,132,021 (4.95%) | $11,560,136 |
Weighted Average Shares Diluted | $23,572,232 (94.30%) | $12,132,021 (4.95%) | $11,560,136 |
Earning Before Interest & Taxes (EBIT) | -$22,456,243 (-493.39%) | -$3,784,378 (-20.67%) | -$3,136,250 |
Gross Profit | -$127,900 (41.15%) | -$217,315 (-91.62%) | -$113,407 |
Operating Income | -$8,374,250 (-123.05%) | -$3,754,436 (-38.51%) | -$2,710,580 |
ONMD Cash Flow Statement (MRY)
Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
Net Cash Flow from Investing | -$43,757 (10.27%) | -$48,766 (-62.90%) | -$29,936 |
Net Cash Flow from Financing | -$8,431,875 (-317.83%) | $3,870,789 (55.17%) | $2,494,468 |
Net Cash Flow from Operations | $8,220,910 (295.32%) | -$4,209,013 (-128.21%) | -$1,844,395 |
Net Cash Flow / Change in Cash & Cash Equivalents | -$254,722 (34.18%) | -$386,990 (37.60%) | -$620,137 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 |
Capital Expenditure | -$43,757 (10.27%) | -$48,766 (-62.90%) | -$29,936 |
Issuance (Repayment) of Debt Securities | -$8,665,399 (-323.87%) | $3,870,789 (55.17%) | $2,494,468 |
Issuance (Purchase) of Equity Shares | -$10,561,243 (0%) | $0 (0%) | $0 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 |
Share Based Compensation | $0 (0%) | $52,754 (-46.10%) | $97,871 |
Depreciation Amortization & Accretion | $27,983 (72.14%) | $16,256 (12.37%) | $14,466 |
ONMD Financial Metrics (MRY)
Metric | 2023 | 2022 | 2021 |
|---|---|---|---|
Gross Margin | -12.50% (48.77%) | -24.40% (-134.62%) | -10.40% |
Profit Margin | -2271.40% (-397.68%) | -456.40% (-69.41%) | -269.40% |
EBITDA Margin | -2195.30% (-417.88%) | -423.90% (-48.27%) | -285.90% |
Return on Average Equity (ROAE) | 183.80% (263.96%) | 50.50% (-62.12%) | 133.30% |
Return on Average Assets (ROAA) | -263.60% (-5757.78%) | -4.50% (10.00%) | -5.00% |
Return on Sales (ROS) | -2198.00% (-416.33%) | -425.70% (-48.17%) | -287.30% |
Return on Invested Capital (ROIC) | -320.90% (-7540.48%) | -4.20% (20.75%) | -5.30% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.83 (-100.24%) | 348 (1416.01%) | 22.95 |
Price to Sales Ratio (P/S) | 18.69 (-86.88%) | 142.48 (33.23%) | 106.94 |
Price to Book Ratio (P/B) | -2.03 (86.12%) | -14.64 (44.75%) | -26.5 |
Debt to Equity Ratio (D/E) | -1.04 (8.24%) | -1.13 (2.25%) | -1.16 |
Earnings Per Share (EPS) | -0.98 (-3366.67%) | 0.03 (-93.18%) | 0.44 |
Sales Per Share (SPS) | 0.04 (-41.10%) | 0.07 (-22.34%) | 0.09 |
Free Cash Flow Per Share (FCFPS) | 0.35 (198.86%) | -0.35 (-116.67%) | -0.16 |
Book Value Per Share (BVPS) | -0.55 (37.88%) | -0.88 (-78.30%) | -0.49 |
Tangible Assets Book Value Per Share (TABVPS) | 0.02 (-82.30%) | 0.11 (48.68%) | 0.08 |
Enterprise Value Over EBIT (EV/EBIT) | -2 (95.24%) | -42 (12.50%) | -48 |
Enterprise Value Over EBITDA (EV/EBITDA) | -1.79 (95.75%) | -42.08 (12.76%) | -48.23 |
Asset Turnover | 0.12 (1060.00%) | 0.01 (-44.44%) | 0.02 |
Current Ratio | 0.03 (-78.79%) | 0.13 (-24.57%) | 0.17 |
Dividends | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | $8,177,153 (292.05%) | -$4,257,779 (-127.16%) | -$1,874,331 |
Enterprise Value (EV) | $40,134,815 (-74.69%) | $158,549,304 (5.30%) | $150,565,072 |
Earnings Before Tax (EBT) | -$23,205,456 (-471.98%) | -$4,057,060 (-37.95%) | -$2,940,869 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$22,428,260 (-495.21%) | -$3,768,122 (-20.70%) | -$3,121,784 |
Invested Capital | -$7,315,693 (-650.52%) | $1,328,878 (303.34%) | $329,472 |
Working Capital | -$12,468,872 (-46.39%) | -$8,517,504 (-117.40%) | -$3,917,872 |
Tangible Asset Value | $463,057 (-66.30%) | $1,374,028 (55.60%) | $883,060 |
Market Capitalization | $26,133,307 (-83.27%) | $156,184,227 (3.37%) | $151,098,778 |
Average Equity | -$12,626,362 (-57.10%) | -$8,037,114 (-264.35%) | -$2,205,859 |
Average Assets | $8,804,124 (-90.16%) | $89,495,040 (51.02%) | $59,261,840 |
Invested Capital Average | $6,998,710 (-92.18%) | $89,524,456 (52.37%) | $58,754,792 |
Shares | 32,263,342 (115.66%) | 14,960,175 (-0.00%) | 14,960,275 |
